Molecular Pharmacology: 39 (3)

March 01, 1991; Volume 39,Issue 3

You have access
Noncompetitive inhibition of gamma-aminobutyric acidA channels by Zn.
P Legendre and G L Westbrook

Molecular Pharmacology March 1991, 39 (3) 267-274;
You have access
Induction of cytochrome P450IIE1 in the obese overfed rat.
J L Raucy, J M Lasker, J C Kraner, D E Salazar, C S Lieber and G B Corcoran

Molecular Pharmacology March 1991, 39 (3) 275-280;
You have access
Inhibition of cell colony formation by selenite: involvement of glutathione.
P B Caffrey and G D Frenkel

Molecular Pharmacology March 1991, 39 (3) 281-284;
You have access
Induction of megabase DNA fragments by 5-fluorodeoxyuridine in human colorectal tumor (HT29) cells.
C E Dusenbury, M A Davis, T S Lawrence and J Maybaum

Molecular Pharmacology March 1991, 39 (3) 285-289;
You have access
Affinity labeling of mu and kappa receptors with naloxone benzoylhydrazone.
K M Standifer, L R Murthy, K Kinouchi, L Steele and G W Pasternak

Molecular Pharmacology March 1991, 39 (3) 290-298;
You have access
Selective inhibition of sequence-specific protein-DNA interactions by incorporation of 6-thioguanine: cleavage by restriction endonucleases.
L M Iwaniec, J J Kroll, W M Roethel and J Maybaum

Molecular Pharmacology March 1991, 39 (3) 299-306;
You have access
Influence of the Ah locus on the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the hepatic epidermal growth factor receptor.
F H Lin, G Clark, L S Birnbaum, G W Lucier and J A Goldstein

Molecular Pharmacology March 1991, 39 (3) 307-313;
You have access
Transformation of 5-hydroperoxyeicosatetraenoic acid into dihydroxy- and cysteinyl-leukotrienes by rat hepatocytes: effects of glutathione.
J Huwyler, M Bürgin, T Zeugin and J Gut

Molecular Pharmacology March 1991, 39 (3) 314-323;
You have access
Thymopoietin, a potent antagonist at nicotinic receptors in C2 muscle cell cultures.
M Quik, H el-Bizri, T Audhya and G Goldstein

Molecular Pharmacology March 1991, 39 (3) 324-331;
You have access
Short chain and long chain alkanols have different sites of action on nicotinic acetylcholine receptor channels from Torpedo.
S C Wood, S A Forman and K W Miller

Molecular Pharmacology March 1991, 39 (3) 332-338;
You have access
Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter.
J W Boja, M A Rahman, A Philip, A H Lewin, F I Carroll and M J Kuhar

Molecular Pharmacology March 1991, 39 (3) 339-345;
You have access
Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
C W Lin, K Shiosaki, T R Miller, D G Witte, B R Bianchi, C A Wolfram, H Kopecka, R Craig, F Wagenaar and A M Nadzan

Molecular Pharmacology March 1991, 39 (3) 346-351;
You have access
Block of single batrachotoxin-activated Na+ channels by clofilium.
J Nettleton, N A Castle and G K Wang

Molecular Pharmacology March 1991, 39 (3) 352-358;
You have access
Carbachol activates a novel sodium current in isolated guinea pig ventricular myocytes via M2 muscarinic receptors.
K Matsumoto and A J Pappano

Molecular Pharmacology March 1991, 39 (3) 359-363;
You have access
Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells.
R Y Kanterman, L C Mahan, E M Briley, F J Monsma, D R Sibley, J Axelrod and C C Felder

Molecular Pharmacology March 1991, 39 (3) 364-369;
You have access
cAMP analogs inhibit gamma-aminobutyric acid-gated chloride flux and activate protein kinase A in brain synaptoneurosomes.
R D Schwartz, G Heuschneider, P P Edgar and J A Cohn

Molecular Pharmacology March 1991, 39 (3) 370-375;
You have access
Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
T J Torphy, H L Zhou, M Burman and L B Huang

Molecular Pharmacology March 1991, 39 (3) 376-384;
You have access
Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.
Y Itzhak, D Mash, S H Zhang and I Stein

Molecular Pharmacology March 1991, 39 (3) 385-393;
You have access
Correlation between gamma-aminobutyric acidA receptor ligand-induced changes in t-butylbicyclophosphoro[35S]thionate binding and 36Cl- uptake in rat cerebrocortical membranes.
W B Im and D P Blakeman

Molecular Pharmacology March 1991, 39 (3) 394-398;
You have access
Serum-induced sensitization of cyclic AMP accumulation in 1321N1 human astrocytoma cells.
R A Johnson, L J Arneson-Rotert, J M Hoffman and M L Toews

Molecular Pharmacology March 1991, 39 (3) 399-406;
You have access
Renal alpha 1-adrenergic receptor subtypes: MDCK-D1 cells, but not rat cortical membranes possess a single population of receptors.
K Klijn, S R Slivka, K Bell and P A Insel

Molecular Pharmacology March 1991, 39 (3) 407-413;
You have access
Futile cycling of a sulfate conjugate by isolated hepatocytes.
F C Kauffman, M Whittaker, I Anundi and R G Thurman

Molecular Pharmacology March 1991, 39 (3) 414-420;
You have access
Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
C S Murphy, C J Parker, R McCague and V C Jordan

Molecular Pharmacology March 1991, 39 (3) 421-428;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals